| For: | Ren LL, Mao T, Meng P, Zhang L, Wei HY, Tian ZB. Glutamine addiction and therapeutic strategies in pancreatic cancer. World J Gastrointest Oncol 2023; 15(11): 1852-1863 [PMID: 38077649 DOI: 10.4251/wjgo.v15.i11.1852] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v15/i11/1852.htm |
| Number | Citing Articles |
| 1 |
Sridevi Mardham, Soumya Dakshinamurthy. Immune Therapy for Pancreatic and Colon Cancers. 2025; doi: 10.1016/B978-0-443-24742-2.00001-0
|
| 2 |
Min Su, Huan Qin, Jie Shen, Hao An, Yu Cao. Beyond the tumor: Enhancing pancreatic cancer therapy through glutamine metabolism and innovative drug delivery. Journal of Cell Communication and Signaling 2025; 19(3) doi: 10.1002/ccs3.70033
|
| 3 |
Mahdi Maleki Aghdam, Lotfollah Rezagholizadeh, Aliakbar Fazaeli, Alireza Moradi, Masoud Ojarudi. Nutritional modulation of metabolic signaling within the tumor microenvironment for cancer therapy. Molecular and Cellular Biochemistry 2026; 481(3) doi: 10.1007/s11010-025-05462-1
|
| 4 |
Yan Chen, Zixu Wu, Wenzhe Si, Xujun Liu. The metabolic escape: how tumor metabolic reprogramming drives drug resistance. PeerJ 2026; 14 doi: 10.7717/peerj.21400
|
| 5 |
Xiangpeng Kong, Haiqin Ren, Ke Pei, Yajun Yao, Zhigang Liang, Yunfeng Xue, Shuang Liang, Tongtong Li, Jing Zhang, Yuxia Guo, Miaorong Pei, Huifeng Li. Unveiling therapeutic targets and preventive components for kidney insufficiency and blood stasis-type BPH: bridging metabolomics, network pharmacology and reverse screening. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1584766
|
| 6 |
Dong-Hwan Kim, Dong Joon Kim, Seong-Jun Park, Won-Jun Jang, Chul-Ho Jeong. Inhibition of GLS1 and ASCT2 Synergistically Enhances the Anticancer Effects in Pancreatic Cancer Cells. Journal of Microbiology and Biotechnology 2025; 35 doi: 10.4014/jmb.2412.12032
|
| 7 |
Meijin Wang, Yunlu Zhang, Zhenhua Li, Li Fu. Reprogramming of amino acid metabolism in breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2025; 1880(5) doi: 10.1016/j.bbcan.2025.189412
|
| 8 |
Yan Zhang, Wancheng Li, Jubao Niu, Zeyang Fan, Xin Li, Hui Zhang. Reprogramming of glucose metabolism in pancreatic cancer: mechanisms, implications, and therapeutic perspectives. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1586959
|
| 9 |
Huanyu Wang, Yang Gui, Ke Lv. Molecular Imaging: Unveiling Metabolic Abnormalities in Pancreatic Cancer. International Journal of Molecular Sciences 2025; 26(11) doi: 10.3390/ijms26115242
|
| 10 |
Subasree Sridhar, G. K. Suraishkumar. Machine learning and metabolic modeling-based identification of hypoxia-driven metabolic signatures in pediatric cancers. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1810370
|
| 11 |
Fatima I. AlMaazmi, Lara J. Bou Malhab, Leen ElDohaji, Maha Saber-Ayad. Deciphering the Controversial Role of TP53 Inducible Glycolysis and Apoptosis Regulator (TIGAR) in Cancer Metabolism as a Potential Therapeutic Strategy. Cells 2025; 14(8) doi: 10.3390/cells14080598
|